Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

OptimizeRx (OPRX) Return on Capital Employed (2016 - 2025)

OptimizeRx's Return on Capital Employed history spans 15 years, with the latest figure at 0.04% for Q3 2025.

  • For Q3 2025, Return on Capital Employed rose 23.0% year-over-year to 0.04%; the TTM value through Sep 2025 reached 0.04%, up 23.0%, while the annual FY2024 figure was 0.09%, 10.0% up from the prior year.
  • Return on Capital Employed for Q3 2025 was 0.04% at OptimizeRx, up from 0.03% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.04% in Q3 2025 and bottomed at 0.19% in Q4 2023.
  • The 5-year median for Return on Capital Employed is 0.08% (2022), against an average of 0.08%.
  • The largest annual shift saw Return on Capital Employed fell -10bps in 2022 before it increased 23bps in 2025.
  • A 5-year view of Return on Capital Employed shows it stood at 0.0% in 2021, then plummeted by -3546bps to 0.1% in 2022, then plummeted by -100bps to 0.19% in 2023, then soared by 53bps to 0.09% in 2024, then surged by 149bps to 0.04% in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Return on Capital Employed are 0.04% (Q3 2025), 0.03% (Q2 2025), and 0.07% (Q1 2025).